Startseite Über uns Köpfe Prof. Dr. Angela Zink
Programmbereich Epidemiologie und Versorgungsforschung, stellvertretende Direktorin
Prof. Dr. Angela Zink

Programmbereich Epidemiologie und Versorgungsforschung, stellvertretende Direktorin

Prof. Dr. Angela Zink

Deutsches Rheuma-Forschungszentrum Berlin
Charitéplatz 1
10117 Berlin
Tel: +49 (0)30 28460-622 Fax: +49 (0)30 28460-626 zink@drfz.de

CV - Akademischer Werdegang und Schlüsselpublikationen (nur auf Englisch verfügbar)

Scientific Career
  • Since 2003 Professor of Epidemiology of the Rheumatic Diseases, Charité University Medicine Berlin
  • Since 1996 Deputy Scientific Director of the German Rheumatism Research Centre, Berlin (DRFZ)
  • Since 1991 Head of the DRFZ Programme Area Epidemiology
  • 1985 – 1991 Head of Department of Epidemiology and Health Services Research at GSD Health Systems Research Ltd., Berlin
  • 1977 – 1985 Research and Teaching in Epidemiology and Medical Sociology in various Research Institutes and the Free University of Berlin
Education
  • 1998 Habilitation in Epidemiology (Charité Berlin)
  • 1984 PhD in Medical Sociology (Free University of Berlin)
  • 1972 – 1977 Studies of Sociology, Psychology and Economics; Diploma from Free University of Berlin in 1977
Boards
  • From 2018 Member of the Scientific Committee of FOREUM (Foundation for Research in Rheumatology)
  • Since 2013 Member of Leibniz Prize Jury
  • Since 2012 Faculty/host of annual EULAR Advanced Epidemiology Course
  • Since 2006 Member of several EULAR task forces and working groups
  • Since 2005 Editor Zeitschrift fuer Rheumatologie
  • Since 2005 Member of several committees for professorships at the Charité University Medicine
  • Since 2002 Member of the Advisory Board of the German Society for Rheumatology
  • Since 2000 Speaker of Health Services Research Section of Competence Network Rheumatology
  • 2009 – 2012 Chair / past chair of Standing Committee on Epidemiology of EULAR (European League against Rheumatism)
  • 2006 – 2011 Speaker (2006-07) and deputy speaker (2008-2011) of German Competence Network Rheumatology
Memberships
  • Honorary member of EULAR
  • American College for Rheumatology
  • German Society for Rheumatology
  • German Society for Social Medicine and Prevention
  • German Society for Epidemiology
  • German Society for Medical Sociology
  • German Network Healthcare Research
Awards
  • 2016 Carol-Nachman-Medal
  • 2010 Rheo Price of Progress
  • 2010 Francois-Blondel-Medal
  • 1999 Federal Cross of Merit
  • 1997 Tosse Prize
Third Party Funding (Selection)
  • 2011 – 2018 National Database of the Arthritis Centres (unconditional grant from industry consortium, 900,000 EUR)
  • 2015 – 2018 PROCLAIR and Metarthros (BMBF: 685.000 EUR)
  • 2011 – 2018 RABBIT – Biologics Register in RA (unconditional grant from industry consortium, jointly with Strangfeld, 50% of total = 3,500,000 EUR)
Top Publications (2016-2018)
  1. Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D. Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Ann Rheum Dis 2018 Mar 10 (online first)
  2. Albrecht K, Luque Ramos A, Hoffmann F, Redeker I, Zink A. High prevalence of diabetes in patients with rheumatoid arthritis: Results from a questionnaire survey linked to claims data. Rheumatology (Oxford). 2018; 57(2):329-336
  3. Baganz L, Richter A, Kekow J, Bussmann A, Krause A, Stille C, Listing J, Zink A, Strangfeld A. Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohort. Rheumatol Int 2018; 38(4):579-587
  4. Albrecht K, Huscher D, Buttgereit F, Aringer M, Hoese G, Ochs W, Thiele K, Zink A. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database. Rheumatol Int. 2018 Apr;38(4):569-577.
  5. Meissner Y, Richter A, Manger B, Tony HP, Wilden E, Listing J, Zink A, Strangfeld A. Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. Ann Rheum Dis 2017; 76(9):1583-1590.
  6. Strangfeld A, Richter A, Siegmund B, Herzer P, Rockwitz K, Demary W, Aringer M, Meissner Y, Zink A, Listing J. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. Ann Rheum Dis 2017; 76(3):504-510.
  7. Callhoff J, Luque Ramos A, Zink A, Hoffmann F, Albrecht K. The Association of Low Income with Functional Status and Disease Burden in German Patients with Rheumatoid Arthritis: Results of a Cross-sectional Questionnaire Survey Based on Claims Data. J Rheumatol. 2017;44(6):766-772
  8. Albrecht K, Richter A, Callhoff J, Huscher D, Schett G, Strangfeld A, Zink A. Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases. Arthritis Res Ther 2016; 18:149
  9. Callhoff J, Luque Ramos A, Zink A, Hoffmann F, Albrecht K. The Association of Low Income with Functional Status and Disease Burden in German Patients with Rheumatoid Arthritis: Results of a Cross-sectional Questionnaire Survey Based on Claims Data. J Rheumatol 2017; 44(6):766-772.
  10. Albrecht K, Callhoff J, Buttgereit F, Straub RH, Westhoff G, Zink A. Association Between the Use of Oral Contraceptives and Patient-Reported Outcomes in an Early Arthritis Cohort. Arthritis Care Res (Hoboken ) 2016;68(3):400-405.
AG Zink
Gesundheitsversorgung und Lebensqualität rheumakranker Menschen verbessern
Strukturen des DRFZ
Gremien und Organigramm